Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

A recent study published in The Journal of Allergy and Clinical Immunology: In Practice found that gestational diabetes ...

The FDA approval of Airsupra permits use for as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older.

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

Yes, people have died from asthma, including children and adults. Learn about socioeconomic variables and comorbid factors in ...

The remaining 11 subjects were not offered inhaled HTS due to history of asthma or recent haemoptysis ... to spirometric baseline (at least 90% of the best FEV 1 in the 6 months previous to an ...

acute exacerbations, quality of life and mortality. Asthma is a syndrome consisting of similar phenotypes with characteristic but nonspecific symptoms. COPD is a syndrome akin to asthma but with ...

Broncho-Vaxom is under clinical development by OM Pharma and currently in Phase I for Allergic Asthma. According to GlobalData, Phase I drugs for Allergic Asthma have a 78% phase transition success ...

Many people’s symptoms worsen during the winter period. “We call this an exacerbation or a flare up, when you get ...

The following is a summary of “Clinical remission attainment, definitions, and correlates among patients with severe asthma ...

"For me, preventing exacerbations, and particularly those that lead to hospitalisations, is a treatment priority for the people I see with severe asthma," he added. "Not only are exacerbations ...